Tag Ponatinib

Ponatinib, sold under the brand name Iclusig, is a third-generation tyrosine kinase inhibitor (TKI) medication used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).